Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 2,777,777 | 2,755,555 | -22,222 | $1.51B | $1.49B | 15.41% | -$11.88M |
| Ascendis Pharma A/S(ASND) | 5,111,111 | 5,050,000 | -61,111 | $1.36B | $1.15B | 11.87% | -$212.69M |
| Krystal Biotech, Inc.(KRYS) | 2,888,888 | 2,888,888 | 0 | $1.07B | $960.73M | 9.91% | -$112.98M |
| argenx SEADR(ARGX) | 1,000,000 | 1,000,000 | 0 | $927.77M | $958.91M | 9.89% | +$31.14M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,833,333 | 1,833,333 | 0 | $984.41M | $923.93M | 9.53% | -$60.48M |
| Kymera Therapeutics, Inc.(KYMR) | 7,474,747 | 7,474,747 | 0 | $857.13M | $835.60M | 8.62% | -$21.53M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 11,355,555 | 11,000,000 | -355,555 | $925.59M | $719.95M | 7.43% | -$205.64M |
| Revolution Medicines, Inc.(RVMD) | 2,297,000 | 2,145,000 | -152,000 | $430.18M | $440.28M | 4.54% | +$10.10M |
| Cytokinetics, Incorporated(CYTK) | 4,999,999 | 4,900,000 | -99,999 | $425.95M | $322.96M | 3.33% | -$102.99M |
| Definium Therapeutics, Inc.(DFTX) | 7,188,888 | 7,050,000 | -138,888 | $338.17M | $268.32M | 2.77% | -$69.84M |
| Structure Therapeutics IncADS | 6,555,555 | 6,555,555 | 0 | $351.84M | $204.99M | 2.12% | -$146.84M |
| Xenon Pharmaceuticals Inc.(XENE) | 5,777,777 | 5,500,000 | -277,777 | $348.75M | $204.54M | 2.11% | -$144.20M |
| Vera Therapeutics, Inc.(VERA) | 5,723,888 | 5,635,000 | -88,888 | $245.61M | $181.95M | 1.88% | -$63.66M |
| uniQure N.V.(QURE) | 6,727,777 | 6,727,777 | 0 | $309.88M | $162.54M | 1.68% | -$147.34M |
| Celcuity Inc.(CELC) | 3,400,000 | 1,500,000 | -1,900,000 | $355.71M | $119.28M | 1.23% | -$236.43M |
| Taysha Gene Therapies, Inc.(TSHA) | 23,888,888 | 23,888,888 | 0 | $162.68M | $116.34M | 1.20% | -$46.34M |
| Ocular Therapeutix, Inc.(OCUL) | 12,540,000 | 12,380,300 | -159,700 | $123.14M | $94.96M | 0.98% | -$28.19M |
| Damora Therapeutics Inc | 0 | 3,783,000 | +3,783,000 | $0 | $80.50M | 0.83% | +$80.50M |
| Hemab Therapeutics Hldgs Inc | 1,925,150 | 1,892,372 | -32,778 | $70.71M | $58.36M | 0.60% | -$12.35M |
| Viridian Therapeutics, Inc.(VRDN) | 2,500,000 | 2,500,000 | 0 | $45.92M | $51.48M | 0.53% | +$5.55M |
| Septerna, Inc.(SEPN) | 1,337,500 | 1,300,000 | -37,500 | $44.79M | $50.87M | 0.52% | +$6.08M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 488,000 | +488,000 | $0 | $48.32M | 0.50% | +$48.32M |
| Scribe Therapeutics Inc | 0 | 2,598,973 | +2,598,973 | $0 | $47.83M | 0.49% | +$47.83M |
| Faeth Therapeutics, Inc.(FTH) | 1,444,039 | 1,410,000 | -34,039 | $36.10M | $41.93M | 0.43% | +$5.83M |
| GH Research PLC(GHRS) | 1,800,000 | 1,770,000 | -30,000 | $48.38M | $41.56M | 0.43% | -$6.82M |
| Biohaven Ltd | 0 | 2,750,000 | +2,750,000 | $0 | $36.71M | 0.38% | +$36.71M |
| Avalo Therapeutics, Inc.(AVTX) | 2,333,333 | 2,377,777 | +44,444 | $43.12M | $36.45M | 0.38% | -$6.67M |
| Braveheart Bio Inc | 0 | 1,255,000 | +1,255,000 | $0 | $25.35M | 0.26% | +$25.35M |
| Whitehawk Therapeutics, Inc.(WHWK) | 2,849,402 | 2,849,402 | 0 | $13.05M | $10.71M | 0.11% | -$2.34M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,489,189 | 525,000 | -964,189 | $6.93M | $1.77M | 0.02% | -$5.16M |
| Damora Therapeutics, Inc.(DMRA) | 3,783,000 | 0 | -3,783,000 | $98.40M | $0 | — | -$98.40M |